Annual Accounts Receivable
$19.93 M
-$14.01 M-41.28%
31 December 2023
Summary:
OptiNose annual accounts receivable is currently $19.93 million, with the most recent change of -$14.01 million (-41.28%) on 31 December 2023. During the last 3 years, it has fallen by -$15.52 million (-43.79%). OPTN annual accounts receivable is now -43.79% below its all-time high of $35.45 million, reached on 31 December 2021.OPTN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$29.77 M
+$8.95 M+43.00%
30 September 2024
Summary:
OptiNose quarterly accounts receivable is currently $29.77 million, with the most recent change of +$8.95 million (+43.00%) on 30 September 2024. Over the past year, it has increased by +$9.85 million (+49.41%). OPTN quarterly accounts receivable is now -16.01% below its all-time high of $35.45 million, reached on 31 December 2021.OPTN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPTN Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +49.4% |
| 3 y3 years | -43.8% | -16.0% |
| 5 y5 years | +46.0% | +118.2% |
OPTN Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.8% | at low | -16.0% | +109.3% |
| 5 y | 5 years | -43.8% | +46.0% | -16.0% | +153.8% |
| alltime | all time | -43.8% | -16.0% |
OptiNose Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.77 M(+43.0%) |
| June 2024 | - | $20.82 M(+46.3%) |
| Mar 2024 | - | $14.23 M(-28.6%) |
| Dec 2023 | $19.93 M(-41.3%) | $19.93 M(-6.8%) |
| Sept 2023 | - | $21.37 M(-3.4%) |
| June 2023 | - | $22.13 M(+30.3%) |
| Mar 2023 | - | $16.98 M(-50.0%) |
| Dec 2022 | $33.93 M(-4.3%) | $33.93 M(+27.5%) |
| Sept 2022 | - | $26.62 M(+3.3%) |
| June 2022 | - | $25.77 M(+13.5%) |
| Mar 2022 | - | $22.70 M(-36.0%) |
| Dec 2021 | $35.45 M | $35.45 M(+47.2%) |
| Sept 2021 | - | $24.09 M(+16.3%) |
| June 2021 | - | $20.71 M(+15.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $17.96 M(-23.2%) |
| Dec 2020 | $23.39 M(+71.5%) | $23.39 M(+33.5%) |
| Sept 2020 | - | $17.52 M(+24.3%) |
| June 2020 | - | $14.10 M(+20.1%) |
| Mar 2020 | - | $11.73 M(-14.0%) |
| Dec 2019 | $13.64 M(+490.6%) | $13.64 M(+27.0%) |
| Sept 2019 | - | $10.75 M(+15.4%) |
| June 2019 | - | $9.31 M(+60.7%) |
| Mar 2019 | - | $5.79 M(+150.8%) |
| Dec 2018 | $2.31 M(>+9900.0%) | $2.31 M(-21.0%) |
| Sept 2018 | - | $2.92 M(-20.4%) |
| June 2018 | - | $3.67 M(+79.2%) |
| Mar 2018 | - | $2.05 M(>+9900.0%) |
| Dec 2017 | $0.00 | $0.00 |
FAQ
- What is OptiNose annual accounts receivable?
- What is the all time high annual accounts receivable for OptiNose?
- What is OptiNose quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for OptiNose?
- What is OptiNose quarterly accounts receivable year-on-year change?
What is OptiNose annual accounts receivable?
The current annual accounts receivable of OPTN is $19.93 M
What is the all time high annual accounts receivable for OptiNose?
OptiNose all-time high annual accounts receivable is $35.45 M
What is OptiNose quarterly accounts receivable?
The current quarterly accounts receivable of OPTN is $29.77 M
What is the all time high quarterly accounts receivable for OptiNose?
OptiNose all-time high quarterly accounts receivable is $35.45 M
What is OptiNose quarterly accounts receivable year-on-year change?
Over the past year, OPTN quarterly accounts receivable has changed by +$9.85 M (+49.41%)